244 related articles for article (PubMed ID: 24297595)
1. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
Linda A; Zuiani C; Londero V; Di Gaetano E; Dal Col A; Girometti R; Bazzocchi M
Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications.
Jiang Y; Lou J; Wang S; Zhao Y; Wang C; Wang D
PLoS One; 2014; 9(6):e99669. PubMed ID: 24927476
[TBL] [Abstract][Full Text] [Related]
5. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
[TBL] [Abstract][Full Text] [Related]
6. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
8. US and MRI in the evaluation of mammographic BI-RADS 4 and 5 microcalcifications.
Hrkac Pustahija A; Ivanac G; Brkljacic B
Diagn Interv Radiol; 2018 Jul; 24(4):187-194. PubMed ID: 30091708
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the diagnostic value of contrast-enhanced breast MR imaging and mammography on patients with BI-RADS 3-5 microcalcifications.
Li E; Li J; Song Y; Xue M; Zhou C
PLoS One; 2014; 9(11):e111217. PubMed ID: 25365327
[TBL] [Abstract][Full Text] [Related]
10. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
11. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
12. Positive predictive value of BI-RADS MR imaging.
Mahoney MC; Gatsonis C; Hanna L; DeMartini WB; Lehman C
Radiology; 2012 Jul; 264(1):51-8. PubMed ID: 22589320
[TBL] [Abstract][Full Text] [Related]
13. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
Bennani-Baiti B; Dietzel M; Baltzer PA
PLoS One; 2017; 12(11):e0188679. PubMed ID: 29190656
[TBL] [Abstract][Full Text] [Related]
14. Breast MRI as a Problem-solving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing?
Shimauchi A; Machida Y; Maeda I; Fukuma E; Hoshi K; Tozaki M
Acad Radiol; 2018 Mar; 25(3):288-296. PubMed ID: 29191685
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.
Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E
Cancer; 2004 Feb; 100(4):710-4. PubMed ID: 14770425
[TBL] [Abstract][Full Text] [Related]
16. Mammographic characteristics and vacuum-assisted breast biopsy (VABB) of non-palpable breast lesions.
Ventrella V; Tufaro A; Zito FA; Addante M; Stea B; Dentamaro R; D'Amico C; Paradiso A
Acta Radiol; 2011 Jul; 52(6):602-7. PubMed ID: 21565889
[TBL] [Abstract][Full Text] [Related]
17. Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB).
Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E
Ann Oncol; 2004 Mar; 15(3):450-4. PubMed ID: 14998847
[TBL] [Abstract][Full Text] [Related]
18. Is breast MRI a helpful additional diagnostic test in suspicious mammographic microcalcifications?
Baltzer PAT; Bennani-Baiti B; Stöttinger A; Bumberger A; Kapetas P; Clauser P
Magn Reson Imaging; 2018 Feb; 46():70-74. PubMed ID: 29122667
[TBL] [Abstract][Full Text] [Related]
19. [Stereotactic vacuum-assisted breast biopsy--success, histologic accuracy, patient acceptance and optimizing the BI-RADSTM-correlated indication].
Siegmann KC; Wersebe A; Fischmann A; Fersis N; Vogel U; Claussen CD; Müller-Schimpfle M
Rofo; 2003 Jan; 175(1):99-104. PubMed ID: 12525989
[TBL] [Abstract][Full Text] [Related]
20. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
